YOUNGY (002192) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
12 Feb, 2026Executive summary
Revenue for Q3 2024 was ¥153.12 million, down 24.59% year-over-year; year-to-date revenue was ¥403.76 million, down 51.84% year-over-year.
Net profit attributable to shareholders for Q3 was ¥16.80 million, a 69.82% decrease year-over-year; year-to-date net profit was ¥182.77 million, down 48.94%.
The decline in revenue and profit was mainly due to lower sales prices and volumes in the lithium concentrate business, reflecting a challenging market environment for new energy battery materials.
Financial highlights
Gross margin and operating profit both declined significantly, with operating profit for the period at ¥197.79 million, down 49.22% year-over-year.
Basic and diluted EPS for Q3 were both ¥0.0647, down 69.82% year-over-year; year-to-date EPS was ¥0.7039, down 48.94%.
Net cash flow from operating activities for Q3 was ¥352.18 million, up 73.01% year-over-year.
Total assets at period end were ¥4.29 billion, down 2.39% from the previous year-end.
Shareholders’ equity increased 3.26% to ¥3.33 billion.
Outlook and guidance
The company expects continued pressure on lithium concentrate prices and demand, with ongoing market volatility in the new energy sector.
Latest events from YOUNGY
- Lithium output doubled, driving strong profit growth and continued expansion across the value chain.002192
Q4 202524 Mar 2026 - Revenue and profit fell over 45% year-over-year amid weak lithium prices, but cash flow surged.002192
Q2 202412 Feb 2026 - Revenue and profit fell on lithium price declines, but cash flow and balance sheet remain strong.002192
Q4 202412 Feb 2026 - Revenue up 21%, but net profit down 48% as lithium salt prices fell sharply.002192
Q2 202512 Feb 2026 - Revenue up 15%, but net profit and cash flow down sharply amid heavy project investment.002192
Q1 202512 Feb 2026 - Q3 revenue and profit surged on lithium sales, but year-to-date profit declined amid higher costs.002192
Q3 202512 Feb 2026